AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Walgreens Boots Alliance, Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Walgreens Boots Alliance director Bryan C. Hanson received an annual non-employee director share grant of 16,820 common shares on 08/13/2025 as compensation for prior-year services under the company's 2021 Omnibus Incentive Plan. The grant carried a reported price of $0, reflecting compensation rather than a cash purchase, and increased Mr. Hanson’s total beneficial ownership to 47,655 shares. The Form 4 reports the transaction type as an award for director compensation and identifies the reporting person as a company director.

Il direttore di Walgreens Boots Alliance, Bryan C. Hanson, ha ricevuto il 13/08/2025 una concessione annuale di 16.820 azioni ordinarie come componente della retribuzione per il suo ruolo di amministratore non dipendente, ai sensi del piano 2021 Omnibus Incentive Plan dell’azienda. La concessione è stata indicata con un prezzo di $0, a sottolineare che si tratta di compenso e non di un acquisto in contanti, portando la partecipazione complessiva di Hanson a 47.655 azioni. Il modulo 4 descrive la transazione come un premio per compenso da direttore e identifica il dichiarante come amministratore della società.

El director de Walgreens Boots Alliance, Bryan C. Hanson, recibió el 13/08/2025 una adjudicación anual de 16.820 acciones ordinarias como compensación por su desempeño como director no empleado, conforme al Plan Omnibus de Incentivos 2021 de la compañía. La adjudicación figura con un precio reportado de $0, indicando que se trata de compensación y no de una compra en efectivo, y elevó la propiedad beneficiaria total de Hanson a 47.655 acciones. El Formulario 4 describe la operación como una concesión por compensación a director e identifica al declarante como director de la empresa.

월그린스 ë¶€ì¸� ì–¼ë¼ì´ì–¸ìŠ� ì´ì‚¬ì� 브ë¼ì´ì–¸ C. í•¸ìŠ¨ì€ 2025ë…� 8ì›� 13ì� 회사ì� 2021ë…� ì´ê´„ ì¸ì„¼í‹°ë¸Œ 플랜ì—� ë”°ë¼ ë¹„ìž„ì›� ì´ì‚¬ë¡œì„œ ì „ë…„ë� ì„œë¹„ìŠ¤ì— ëŒ€í•� ë³´ìƒìœ¼ë¡œ ì—°ê°„ 16,820ì£¼ì˜ ë³´í†µì£¼ë¥¼ 지급받았습니다. 해당 주ì‹ì€ ë³´ê³ ë� ê°€ê²©ì´ $0ë¡� 표시ë˜ì–´ 현금 구입ì� 아니ë� ë³´ìƒìž„ì„ ë‚˜íƒ€ë‚´ë©°, 핸슨ì� ì´� 실소ìœ� ì£¼ì‹ ìˆ˜ëŠ” 47,655주로 ì¦ê°€í–ˆìŠµë‹ˆë‹¤. Form 4ëŠ� ì� 거래ë¥� ì´ì‚¬ ë³´ìƒì—� 따른 수여ë¡� 기ë¡í•˜ê³  ì‹ ê³ ì¸ì„ 회사 ì´ì‚¬ë¡� ì‹ë³„합니ë‹�.

Le directeur de Walgreens Boots Alliance, Bryan C. Hanson, a reçu le 13/08/2025 une attribution annuelle de 16 820 actions ordinaires en rémunération de ses services en tant qu’administrateur non salarié, au titre du plan d'incitation Omnibus 2021 de la société. L'attribution a été déclarée au prix de 0 $, indiquant qu'il s'agit d'une rémunération et non d'un achat en numéraire, et a porté la détention bénéficiaire totale de M. Hanson à 47 655 actions. Le formulaire 4 qualifie la transaction de prime liée à la rémunération d'un administrateur et identifie le déclarant comme administrateur de la société.

Walgreens Boots Alliance-Direktor Bryan C. Hanson erhielt am 13.08.2025 eine jährliche Zuteilung von 16.820 Stammaktien als Vergütung für seine Tätigkeit als nicht angestellter Direktor unter dem Omnibus-Incentive-Plan 2021 des Unternehmens. Die Zuteilung wurde mit einem angegebenen Preis von $0 versehen, was darauf hinweist, dass es sich um Vergütung und nicht um einen Barerwerb handelt, und erhöhte Hansons Gesamtbeteiligung auf 47.655 Aktien. Das Formular 4 führt die Transaktion als Gewährung zur Direktorenvergütung auf und identifiziert den Meldenden als Unternehmensdirektor.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine annual director equity grant increases insider alignment with shareholders without indicating any change in governance or control.

The reported transaction is a standard non-employee director equity award under the company's omnibus plan, issued in arrears for prior-year service. Such grants are common governance practice to align directors' interests with shareholders and to compensate board service. The award increased beneficial ownership to 47,655 shares, which is a disclosure of ownership level but does not, by itself, signal strategic change, executive turnover, or material governance events.

TL;DR: The Form 4 shows a non-purchase equity grant of 16,820 shares to a director, a routine compensation event with limited market impact.

The transaction code and reported $0 price indicate a compensation grant rather than a market purchase. From an investor-impacted perspective, the size of the grant (16,820 shares) and resulting total ownership (47,655 shares) are disclosed for transparency but are unlikely to materially affect outstanding share count or valuation for a company the size of WBA. No derivative transactions or sales were reported.

Il direttore di Walgreens Boots Alliance, Bryan C. Hanson, ha ricevuto il 13/08/2025 una concessione annuale di 16.820 azioni ordinarie come componente della retribuzione per il suo ruolo di amministratore non dipendente, ai sensi del piano 2021 Omnibus Incentive Plan dell’azienda. La concessione è stata indicata con un prezzo di $0, a sottolineare che si tratta di compenso e non di un acquisto in contanti, portando la partecipazione complessiva di Hanson a 47.655 azioni. Il modulo 4 descrive la transazione come un premio per compenso da direttore e identifica il dichiarante come amministratore della società.

El director de Walgreens Boots Alliance, Bryan C. Hanson, recibió el 13/08/2025 una adjudicación anual de 16.820 acciones ordinarias como compensación por su desempeño como director no empleado, conforme al Plan Omnibus de Incentivos 2021 de la compañía. La adjudicación figura con un precio reportado de $0, indicando que se trata de compensación y no de una compra en efectivo, y elevó la propiedad beneficiaria total de Hanson a 47.655 acciones. El Formulario 4 describe la operación como una concesión por compensación a director e identifica al declarante como director de la empresa.

월그린스 ë¶€ì¸� ì–¼ë¼ì´ì–¸ìŠ� ì´ì‚¬ì� 브ë¼ì´ì–¸ C. í•¸ìŠ¨ì€ 2025ë…� 8ì›� 13ì� 회사ì� 2021ë…� ì´ê´„ ì¸ì„¼í‹°ë¸Œ 플랜ì—� ë”°ë¼ ë¹„ìž„ì›� ì´ì‚¬ë¡œì„œ ì „ë…„ë� ì„œë¹„ìŠ¤ì— ëŒ€í•� ë³´ìƒìœ¼ë¡œ ì—°ê°„ 16,820ì£¼ì˜ ë³´í†µì£¼ë¥¼ 지급받았습니다. 해당 주ì‹ì€ ë³´ê³ ë� ê°€ê²©ì´ $0ë¡� 표시ë˜ì–´ 현금 구입ì� 아니ë� ë³´ìƒìž„ì„ ë‚˜íƒ€ë‚´ë©°, 핸슨ì� ì´� 실소ìœ� ì£¼ì‹ ìˆ˜ëŠ” 47,655주로 ì¦ê°€í–ˆìŠµë‹ˆë‹¤. Form 4ëŠ� ì� 거래ë¥� ì´ì‚¬ ë³´ìƒì—� 따른 수여ë¡� 기ë¡í•˜ê³  ì‹ ê³ ì¸ì„ 회사 ì´ì‚¬ë¡� ì‹ë³„합니ë‹�.

Le directeur de Walgreens Boots Alliance, Bryan C. Hanson, a reçu le 13/08/2025 une attribution annuelle de 16 820 actions ordinaires en rémunération de ses services en tant qu’administrateur non salarié, au titre du plan d'incitation Omnibus 2021 de la société. L'attribution a été déclarée au prix de 0 $, indiquant qu'il s'agit d'une rémunération et non d'un achat en numéraire, et a porté la détention bénéficiaire totale de M. Hanson à 47 655 actions. Le formulaire 4 qualifie la transaction de prime liée à la rémunération d'un administrateur et identifie le déclarant comme administrateur de la société.

Walgreens Boots Alliance-Direktor Bryan C. Hanson erhielt am 13.08.2025 eine jährliche Zuteilung von 16.820 Stammaktien als Vergütung für seine Tätigkeit als nicht angestellter Direktor unter dem Omnibus-Incentive-Plan 2021 des Unternehmens. Die Zuteilung wurde mit einem angegebenen Preis von $0 versehen, was darauf hinweist, dass es sich um Vergütung und nicht um einen Barerwerb handelt, und erhöhte Hansons Gesamtbeteiligung auf 47.655 Aktien. Das Formular 4 führt die Transaktion als Gewährung zur Direktorenvergütung auf und identifiziert den Meldenden als Unternehmensdirektor.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hanson Bryan C

(Last) (First) (Middle)
C/O WALGREENS BOOTS ALLIANCE, INC.
108 WILMOT ROAD

(Street)
DEERFIELD IL 60015

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Walgreens Boots Alliance, Inc. [ WBA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/13/2025 A(1) 16,820 A $0 47,655 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Annual share grant issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan in arrears with respect to services rendered over the course of the prior year.
Remarks:
/s/ Bryan C. Hanson by Cherita Thomas, Attorney-in-Fact 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Walgreen Boots

NASDAQ:WBA

WBA Rankings

WBA Latest News

WBA Latest SEC Filings

WBA Stock Data

10.35B
713.76M
17.44%
61.48%
2.48%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
United States
DEERFIELD